AMBER MCMAHAN: Open Payments
NPI 1952852949 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 105 payments from 22 companies in 2025. Trend: 2023 $1,521 · 2024 $1,740 · 2025 $2,010
Food & beverage: $1,994Education: $17
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 11 | $266 |
| Otsuka America Pharmaceutical, Inc. | 9 | $226 |
| AstraZeneca Pharmaceuticals LP | 9 | $178 |
| Fresenius USA Marketing, Inc. | 9 | $174 |
| OPKO Pharmaceuticals, LLC | 20 | $167 |
| Ardelyx, Inc. | 7 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Vifor Pharma, Inc. | 5 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
Products named: JYNARQUE, FARXIGA, VELPHORO, RAYALDEE, IBSRELA, Kerendia, Veltassa, Fabhalta.
Industry payments across GA — which companies pay providers there.
